pindolol has been researched along with Long QT Syndrome in 2 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Long QT Syndrome: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malfatto, G | 1 |
| Steinberg, SF | 1 |
| Rosen, TS | 1 |
| Danilo, P | 1 |
| Rosen, MR | 1 |
| Nakazato, Y | 1 |
| Nakata, Y | 1 |
| Tokano, T | 1 |
| Ohno, Y | 1 |
| Fujioka, H | 1 |
| Hisaoka, T | 1 |
| Sumiyoshi, M | 1 |
| Ogura, S | 1 |
| Sakurai, H | 1 |
| Yamaguchi, H | 1 |
1 review available for pindolol and Long QT Syndrome
| Article | Year |
|---|---|
Experimental QT interval prolongation.
Topics: Adrenergic beta-Antagonists; Animals; Animals, Newborn; Electrocardiography; Heart Conduction System | 1992 |
1 other study available for pindolol and Long QT Syndrome
| Article | Year |
|---|---|
Long-term follow-up study of three patients with the long QT syndrome.
Topics: Adult; Electrocardiography; Estrogens; Female; Follow-Up Studies; Humans; Long QT Syndrome; Middle A | 1992 |